🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. (SHE:002675)
China flag China · Delayed Price · Currency is CNY
11.85
-0.55 (-4.44%)
Nov 20, 2026, 3:04 PM CST

SHE:002675 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
747.8871.93757.01644.421,022826.61
Trading Asset Securities
245.93225.22148.5420.1227.33129.27
Cash & Short-Term Investments
993.731,097905.55664.531,049955.88
Cash Growth
-14.27%21.16%36.27%-36.65%9.74%14.64%
Accounts Receivable
1,022989.89936.24794.08883.53875.48
Other Receivables
22.235.050.6510.9662.1319.06
Receivables
1,044994.94936.89805.04945.66894.55
Inventory
437.86532.57646.22903.861,078952.53
Other Current Assets
86.4160.2878.99104.25120.0596.81
Total Current Assets
2,5632,6852,5682,4783,1932,900
Property, Plant & Equipment
2,5462,6292,3352,1471,9641,616
Long-Term Investments
416.27383.91356.05212.92191.1243.37
Goodwill
2,4492,4912,5012,5442,3302,373
Other Intangible Assets
268.1281.68252.54219.44226.06191.41
Long-Term Deferred Tax Assets
154.55134.6694.8988.0363.7158.61
Long-Term Deferred Charges
496.37444.73363.02243133.24177.03
Other Long-Term Assets
206.06173.43164.82150.3776.6996.54
Total Assets
9,0999,2248,6358,0828,1777,656

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
486.14583.93588.41876.021,3321,052
Accrued Expenses
122.11337.36281.49240.55255.3216.99
Short-Term Debt
355.96252490.23372.97391.47365.96
Current Portion of Long-Term Debt
124.9668.4464.65147.646.66156.37
Current Portion of Leases
-18.149.3411.394.993.69
Current Income Taxes Payable
94.6557.4947.9653.4656.6136.14
Current Unearned Revenue
106.7787.1106.01114.25108.8268.47
Other Current Liabilities
421.38231.55165.87135.48197.72143.11
Total Current Liabilities
1,7121,6361,7541,9522,3932,043
Long-Term Debt
641.22297.33301.86249.21232.6520.36
Long-Term Leases
128.34140.433.8811.077.532.89
Long-Term Unearned Revenue
202.98192.28196.79236.97240.2747.33
Long-Term Deferred Tax Liabilities
24.0522.6917.4118.118.6316.76
Other Long-Term Liabilities
1,1101,471959.32219.662.222.22
Total Liabilities
3,8183,7603,2632,6872,8952,633

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
824.6824.6824.6824.6824.6802.21
Additional Paid-In Capital
-1,7001,9982,3412,4022,317
Retained Earnings
1,9111,8141,6431,6031,5171,290
Comprehensive Income & Other
1,81611.8114.846.864.84-11.78
Total Common Equity
4,4524,3504,4804,7754,7494,397
Minority Interest
828.91,114891.02620.22533.66626.35
Shareholders' Equity
5,2805,4645,3715,3965,2825,024
Total Liabilities & Equity
9,0999,2248,6358,0828,1777,656

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
1,250776.32899.96792.23683.251,049
Net Cash (Debt)
-256.74320.835.59-127.7365.7-93.39
Net Cash Growth
-5638.53%----
Net Cash Per Share
-0.310.390.01-0.150.45-0.12
Filing Date Shares Outstanding
824.6824.6824.6824.6824.6802.21
Total Common Shares Outstanding
824.6824.6824.6824.6824.6802.21
Working Capital
850.541,049813.69525.96799.34856.82
Book Value Per Share
5.405.285.435.795.765.48
Tangible Book Value
1,7351,5771,7272,0122,1931,833
Tangible Book Value Per Share
2.101.912.092.442.662.28
Buildings
-1,6171,4901,1961,119869.32
Machinery
-1,2911,162943.15870.18747.8
Construction In Progress
-639.8567.91780.03641.37561.05